Daptomycin Administration for Urinary Tract Infections
Dosing Recommendations
- For uncomplicated UTIs caused by vancomycin-resistant enterococci (VRE), daptomycin is administered at 8-12 mg/kg IV once daily 1
- Higher doses (8-12 mg/kg) are recommended over standard dosing for better clinical outcomes, particularly for resistant organisms 1
- Daptomycin should be administered intravenously, as it is not available in oral formulation 2
- Duration of therapy should be individualized based on clinical response, typically 7-14 days depending on infection severity 3
Clinical Considerations
- Creatine kinase (CK) levels should be monitored during treatment due to potential muscle toxicity, especially when using higher doses 1
- Infectious disease consultation is highly recommended when treating multidrug-resistant organism (MDRO) infections, including those requiring daptomycin 4
Alternative Options for VRE UTIs
- For uncomplicated VRE UTIs, consider these alternatives before daptomycin: Nitrofurantoin 100 mg PO every 6 hours 2
- For uncomplicated VRE UTIs, consider these alternatives before daptomycin: Fosfomycin 3 g PO as a single dose 2
- For uncomplicated VRE UTIs, consider these alternatives before daptomycin: High-dose ampicillin (18-30 g IV daily in divided doses) or amoxicillin 500 mg PO/IV every 8 hours (if susceptible) 2
Special Populations
- Daptomycin is not recommended for use in infants <1 year of age 4
Combination Therapy Considerations
- For severe or refractory VRE infections, combination therapy with daptomycin plus β-lactams (including penicillins, cephalosporins, or carbapenems) may be considered 1
- Combination therapy may be particularly beneficial for isolates with higher daptomycin MICs (3-4 mg/mL) 1